Abstract:BackgroundThe accumulation of inorganic arsenic in the liver can lead to liver fibrosis. Solute carrier family 7 member 11 (SLC7A11) and cyclin dependent kinase inhibitor 1A (CDKN1A) are ferroptosis related genes that are abnormally expressed in liver and fibrosis diseases, but their impacts on inorganic arsenic induced liver fibrosis has not been reported yet. ObjectiveTo explore the effect of different doses of sodium arsenite on the migration ability of human hepatic stellate (LX-2) cells and the changes in DNA methylation and expression of SLC7A11 and CDKN1A in LX-2 cell activation induced by sodium arsenite. MethodsLX-2 cells were treated with different doses of sodium arsenite for 24 h. The experiment set up four groups: control group (0 μmol·L−1), low-dose group (5 μmol·L−1), medium-dose group (10 μmol·L−1), and high-dose group (15 μm·L−1). Possible morphological changes of LX-2 cells were observed under an inverted microscope in each group. Cell migration and movement were determined by cell scratch assay. Mitochondrial morphology was observed in the control and the high-dose groups under a transmission electron microscope (TEM). Fe2+ fluorescence intensity was detected with a FerroOrange fluorescence probe. Differentially methylated sites were screened using the Illumina 850 K methylation chip. Ferroptosis related markers (SLC7A11 & CDKN1A) and hepatic stellate cell activation related markers [transforming growth factor-β1 (TGF-β1) and collagen type Ⅲ (Collagen Ⅲ)] were detected by real-time fluorescence quantitative PCR and Western blot. ResultsWith the increase of exposure dose, the cells retracted tentacles and gradually became round, and the healing of cell scratches gradually deteriorated. Destruction of mitochondrial membrane integrity and mitochondrial crista fracture in some cells were observed under a TEM in the high-dose group. Laser confocal microscopy showed that the fluorescence intensity of Fe2+ gradually increased with the increase of exposure dose. The results of methylation chip displayed that compared with the control group, high methylation was found in the high-dose group at the cg22659014 site in the promoter region of SLC7A11, and at the cg17964532 site in the promoter region of CDKN1A. With the increase of exposure dose, the mRNA and protein expression levels of SLC7A11 decreased (P<0.001); the CDKN1A mRNA expression level did not change significantly between groups (P>0.05), and its protein expression levels in the low-, medium-, and high-dose groups were higher than that in the control group (P<0.001). The TGF-β1 mRNA expression levels in the medium- and high-dose groups were higher than that in the control group (P<0.001), and its protein expression levels increased with the increase of exposure dose (P<0.001). The CollagenⅢ mRNA expression level increased with the increase of exposure dose (P<0.001), and its protein expression level was higher only in high-dose group than that in the control group (P<0.001). ConclusionSodium arsenite exposure can weaken the migration ability of LX-2 cells, and the ferroptosis related genes SLC7A11 and CDKN1A are involved in the process of sodium arsenite-induced activation of LX-2 cells.

The activation of TLR4-MyD88 signaling promotes hepatic dysfunction and fibrotic changes in SD rats resulting from prolonged exposure to sodium arsenite

Nod-like receptor protein 3 inflammasome-mediated pyroptosis contributes to chronic NaAsO2 exposure-induced fibrotic changes and dysfunction in the liver of SD rats

Arsenic exposure induced renal fibrosis via regulation of mitochondrial dynamics and the NLRP3‐TGF‐β1/SMAD signaling pathway

PTEN Overexpression Alters Autophagy Levels and Slows Sodium Arsenite-Induced Hepatic Stellate Cell Fibrosis

Arsenic Induces Continuous Inflammation and Regulates Th1/Th2/Th17/Treg Balance in Liver and Kidney In Vivo

Acute Arsenic Exposure Induces Inflammatory Responses and CD4(+) T Cell Subpopulations Differentiation in Spleen and Thymus with the Involvement of MAPK, NF-kB, and Nrf2

Role of SESTRIN2/AMPK/ULK1 pathway activation and lysosomes dysfunction in NaAsO2-induced liver injury under oxidative stress

Imbalanced Immune Responses Involving Inflammatory Molecules and Immune-Related Pathways in the Lung of Acute and Subchronic Arsenic-Exposed Mice.

Mechanism underlying the targeted regulation of the SOD1 3′UTR by the AUF1/Dicer1/miR-155/SOD1 pathway in sodium arsenite-induced liver injury

Mechanisms underlying the combination effect of arsenite and high-fat diet on aggravating liver injury in mice

Filamin A Facilitates NLRP3 Inflammasome Activation During Arsenic-Induced Nonalcoholic Steatohepatitis.

DNA methylation and expression changes of ferroptosis related genes SLC7A11 and CDKN1A in human hepatic stellate cell activation induced by sodium arsenite

Arsenite Induces Apoptosis of Murine T Lymphocytes Through Membrane Raft-Linked Signaling for Activation of C-Jun Amino-Terminal Kinase

Arsenic-induced lung inflammation and fibrosis in a rat model: Contribution of the HMGB1/RAGE, PI3K/AKT, and TGF-β1/SMAD pathways

The Role of BNIP3 and Blocked Autophagy Flux in Arsenic-Induced Oxidative Stress–Induced Liver Injury in Rats

Lipidomic Profiling of Subchronic As4S4 Exposure Identifies Inflammatory Mediators As Sensitive Biomarkers in Rats

Molecular Dissection of the Arsenic-Induced Leukocyte Incursion into the Inflamed Thymus and Spleen and Its Amelioration by Co-supplementation of L-Ascorbic Acid and α-Tocopherol

Active Vitamin D Ameliorates Arsenite-Induced Thyroid Dysfunction in Sprague–Dawley Rats by Inhibiting the Toll-like Receptor 4/NF-KappaB-Mediated Inflammatory Response

Effect of Acetyl-l-Carnitine on Antioxidant Status, Lipid Peroxidation, and Oxidative Damage of Arsenic in Rat

C/EBPβ-TFAM-Mediated NLRP3 Inflammasome Activation Contributes to Arsenic-Induced Rat Kidney Injury

Protective Effects of Selenium on Oxidative Damage and Oxidative Stress Related Gene Expression in Rat Liver under Chronic Poisoning of Arsenic.